Simpson Thacher & Bartlett LLP

15 ranked departments 15 ranked lawyersContact information

Simpson Thacher & Bartlett LLP

15 ranked departments 15 ranked lawyersContact information
about
ranked departments
Ranked Lawyers
ranked offices
about
ranked departments
Ranked Lawyers
ranked offices

Firm profile for Asia-Pacific 2021

Profile view:
Asia-Pacific 2021
Asia-Pacific

This firm is also ranked in:

Global 2021 USA 2020 UK 2021 Europe 2021 Latin America 2021 High Net Worth 2020

About

This content is provided by Simpson Thacher & Bartlett LLP.

Chairman, Executive Committee: William R. Dougherty
Administrative Partners: Jennifer Hobbs, Sasan Mehrara
Head of China Practice:
Celia Lam
Number of partners worldwide: 197
Number of other lawyers worldwide:
Over 800 
Asia Pacific Offices: Beijing, Hong Kong, Tokyo
International Offices: Houston, London, Los Angeles, New York, Palo Alto, São Paulo and Washington, DC

Firm Overview:
Simpson Thacher & Bartlett LLP is widely recognised as one of the preeminent law firms in the world. The firm represents clients with a commitment to hard work, excellence and integrity. The firm has a strong track record in representing leading Asian and global companies, financial institutions and investment firms on significant and complex capital markets, banking and cross-border M&A transactions involving Greater China, Japan, Korea, India, Australia and other parts of Asia and around the globe. The Asian investment funds team reflects the strength of the firm’s preeminent private equity funds practice globally. Through its Asia litigation practice group, the firm provides its Asia-based clients with a comprehensive offering of litigation services, including antitrust, IP, international arbitration, securities and government and internal investigation matters. The firm advises on Hong Kong local law in addition to US and English law. Many attorneys in Asia are native speakers of Mandarin Chinese, Japanese or Korean and have considerable transaction experience throughout the region.

Main Areas of Practice:
■ Capital Markets
■ M&A & Private Equity
■ Banking & Finance
■ Real Estate
■ Investment Funds
■ Asia Litigation Practice Group

Capital Markets:
■ Alibaba Group in its US$25 billion IPO on the NYSE and its US$11 billion secondary listing and public offering on the HKSE
■ IPOs of Chinese companies on both US and HK exchanges including XPeng, Agora, Smoore, Huatai Securities, Qudian, BEST and Qutoutiao
■ IPOs of major Japanese companies including LINE, Mercari, Kyushu Railway and Japan Post
■ IPOs of Korean companies on the KRX including SK Biopharmaceuticals, LOTTE REIT, Samsung BioLogics and Celltrion Healthcare
■ Debt and equity offerings by Alibaba, Ant Financial, Asahi, Baozun, Dai-ichi Life, Daiwa House REIT, Hanwha Life, Japan Post, KEPCO, Kia, Mitsubishi UFJ, Mizuho Financial, Nissan, Nomura, Panasonic, Republic of Korea, Shinhan Bank, Sumitomo Mitsui, Suntory, Takeda Pharmaceutical, Weibo and Zai Lab

M&A & Private Equity:
■ Alibaba in many acquisitions and investments, including Ele.me, Lyft, Tokopedia and Trendyol, and partnership with Starbucks
■ Ant Financial in its US$14 billion Series C equity financing and investments in hellopay, India’s Paytm, Indonesia’s Emtek, Malaysia’s Touch ’n Go, Korea’s Kakaopay, Bangladesh’s bKash, Pakistan’s Telenor Microfinance Bank and Philippines’ Mynt
■ Calsonic Kansei in its US$7.1 billion acquisition of Magneti Marelli
■ ChemChina in its US$43 billion acquisition of Syngenta
■ JOYY Inc. in the sale of YY Live to Baidu
■ SK in its acquisition of AMPAC Fine Chemicals
■ SoftBank in the announced business integration of Z Holdings and LINE
■ “Going private” transactions including of LCY Chemicals, iKang, AutoNavi and Homeinns
■ Blackstone in multiple matters, including the acquisitions of AYUMI Pharmaceutical and Takeda Consumer Healthcare
■ KKR in many acquisitions or investments including: Japan (Calsonic Kansei, Koki Holdings, Seiyu), Korea (LS Auto, Namsam Square), India (EuroKids, IndiGrid, Jio Platforms, Ramky Enviro), Indonesia (Japfa Comfeed), Malaysia (Weststar Aviation), Philippines (Metro Pacific Hospitals, Pinnacle Towers) and Vietnam (Masan, Vinhomes), and sales of AlphaTheta, KCF Technologies and Kokusai Electric

Banking & Finance:
■ SoftBank in a ¥500 billion margin loan financing
■ Ant Financial in a refinancing of syndicated loan agreement
■ Acquisition financing for KKR, including: Japan’s Calsonic Kansei, Kokusai Electric, Koki Holdings and Seiyu, Vietnam’s Vinhomes and Taiwan’s LCY Chemical, as well as various matters in India
■ Blackstone in financing for its acquisitions of Takeda Consumer Healthcare and AYUMI Pharmaceutical
■ Bolt-on acquisition financing for Calsonic Kansei’s acquisition of Magneti Marelli and PHC’s acquisitions of Bayer’s Diabetes Care business division and the Anatomical Patho- logy business of Thermo Fisher
■ Korean banks in connection with the acquisition of Momentive Performance Materials by a consortium
■ Investment funds in fund subscription facilities and back-leverage facilities

Real Estate:
■ Blackstone Real Estate Partners in numerous matters, including its acquisitions of 50% of Taubman Asia’s interests in three Asia-based shopping centers and a stake in Crown Resorts; its listing, with Embassy Group, of the Embassy Office Parks REIT, India’s first-ever REIT; the formation of its JV with Vanke to invest in logistics properties in China; its investment in SCP Company; and its investments in properties in Australia, India and Singapore, as well as various financing matters
■ IndoSpace in its partnership with GLP, in respect of India’s leading logistics properties funds platform
■ KKR in its investment in a mixed-use real estate project in Gangnam, Seoul and sale of BLK Pyeongtaek Logistics Center in Korea’s Pyeongtaek Port

Investment Funds:
Counsel to sponsors on the formation of:
■ Affinity’s US$6 billion fifth Asia Pacific fund
■ Advantage Partners’¥85 billion sixth flagship Japan buyout fund
■ Blackstone’s US$7.1 billion second pan-Asia real estate fund
■ CVC’s US$4.5 billion fifth pan-Asia fund
■ Carlyle’s US$6.55 billion fifth pan-Asia fund
■ J-Star’s ¥48.5 billion Fund IV series
■ PAG’s US$2.75 billion flagship opportunistic real estate fund
■ Polaris’¥150 billion fifth fund series
■ Yunfeng’s US$2.5 billion third China-focused private equity fund
■ Zebra Global’s US$800 million debut fund

Litigation:
■ US-listed, Asia-based clients in many nonpublic DOJ, SEC and FINRA investigations
■ Certain leading private equity firms in M&A-related international arbitrations before the ICC and HKIAC
■ Alibaba in a dozen federal and California state securities litigations and an SEC investigation related to its historic IPO
■ Daiichi Sankyo in recovering over US$525 million in ICC arbitration on fraud claims against the sellers of India’s Ranbaxy
■ Danone as claimant in UNCITRAL arbitration against Fonterra relating to the 2013 botulism crisis across Asia-Pacific
■ Elpida, HannStar, Innolux, LG Display, Stanley Electric and Diamond Electric in global price-fixing cartel litigations
■ Qudian Inc. in securities litigations in California and New York

Asia-Pacific

This firm is also ranked in:

Global 2021 USA 2020 UK 2021 Europe 2021 Latin America 2021 High Net Worth 2020

Contributions

Total 4 contributions

Ranked Departments

This content is provided by Chambers based on our research. Learn more about our methodology.

Find this firm’s ranked departments based on your requirements using the Location, Practice Area or Band filter below.

Filter by

Band
Asia-Pacific Region

Capital Markets: Debt
Band 3
Capital Markets: Equity
Band 2
Corporate/M&A
Band 3
Corporate/M&A: Private Equity
Band 2
Investment Funds: Private Equity
Band 1
China

Banking & Finance: Leveraged & Acquisition Finance (International Firms)
Band 3

Ranked Lawyers

This content is provided by Chambers based on our research. Learn more about our methodology.

Find this firm’s ranked individuals based on your requirements using the Location, Practice Area or Band filter below.

Filter by

Band
China

Banking & Finance: Leveraged & Acquisition Finance (International Firms)


Makiko Harunari
Up and Coming

Capital Markets: Equity (International Firms)


Chris Lin
Band 2
Christopher Wong
Band 2

Corporate/M&A: China-based (International Firms)


Corporate/M&A: Hong Kong-based (International Firms)


Top Ranked Lawyers

Band 1
Alan CannonCapital Markets: International: US Law
Band 2
Celia LamCapital Markets: Equity (International Firms)
Christopher WongCapital Markets: Equity (International Firms)
Jin-Hyuk ParkCapital Markets: International Firms
Adam FurberInvestment Funds (International Firms)
David AzcueInvestment Funds: Registered Foreign Lawyers
Band 3
Yang WangCorporate/M&A: China-based (International Firms)
Jin-Hyuk ParkCorporate/M&A: International Firms
Band 4
Ian HoPrivate Equity: Buyouts & Venture Capital Investment (International Firms)
Yang WangPrivate Equity: Buyouts & Venture Capital Investment (International Firms)
Band 5
Ian HoCorporate/M&A: Hong Kong-based (International Firms)

Ranked Offices

This content is provided by Chambers based on our research. Learn more about our methodology.

China

Beijing
Hong Kong
Japan

Tokyo

Ranked Offices

Head Office

firm
Head Office

425 Lexington Avenue

New York

New York

USA

NY 10017-3954

View head office profile